UroQuant BC Test

About Uroquant

Uroquant is a private, pre-revenue diagnostics company focused on transforming bladder cancer detection. Its core technology is a mass spectrometry-based assay that detects specific protein biomarkers from a simple urine sample, offering high sensitivity and a non-invasive patient experience. The company is positioned to address significant unmet needs in urological diagnostics, particularly for monitoring and initial detection, though it faces competition and the challenge of achieving clinical adoption and reimbursement. Uroquant's success hinges on validating its test, securing regulatory approvals, and successfully commercializing its product.

Therapeutic Areas